Janux Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD from Q3 2021 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Janux Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and growth rate from Q3 2021 to Q2 2024.
- Janux Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending June 30, 2024 was $3.51M, a 3% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Growth (%)